186 related articles for article (PubMed ID: 31776570)
1. Cutaneous leishmaniasis with secondary mucosal disease in a traveller due to Leishmania (Viannia) braziliensis.
Crone CG; Helleberg M
J Travel Med; 2020 Feb; 27(1):. PubMed ID: 31776570
[No Abstract] [Full Text] [Related]
2. Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelers.
Eichner S; Thoma-Uszynski S; Herrgott I; Sebald H; Debus A; Tsianakas A; Ehrchen J; Harms G; Simon M; Sunderkötter C; Bogdan C
Eur J Dermatol; 2013 Apr; 23(2):218-23. PubMed ID: 23557633
[TBL] [Abstract][Full Text] [Related]
3. Mucosal Leishmania infantum infection.
Richter J; Hanus I; Häussinger D; Löscher T; Harms G
Parasitol Res; 2011 Sep; 109(3):959-62. PubMed ID: 21499751
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Mucosal Leishmaniasis in New York City.
Murray HW; Eiras DP; Kirkman LA; Chai RL; Caplivski D
Am J Trop Med Hyg; 2020 Jun; 102(6):1319-1322. PubMed ID: 32228792
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous occurrence of cutaneous and mucocutaneous leishmaniasis caused by different genotypes of Leishmania (Viannia) braziliensis.
Hoyos CL; Quipildor M; Bracamonte E; Lauthier JJ; Cajal P; Uncos A; Korenaga M; Hashiguchi Y; Barroso PA; Marco JD
J Dermatol; 2019 Sep; 46(9):e320-e322. PubMed ID: 30938461
[No Abstract] [Full Text] [Related]
6. Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel.
Solomon M; Sahar N; Pavlotzky F; Barzilai A; Jaffe CL; Nasereddin A; Schwartz E
Emerg Infect Dis; 2019 Apr; 25(4):642-648. PubMed ID: 30882319
[TBL] [Abstract][Full Text] [Related]
7. Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate.
Basile G; Cristofaro G; Locatello LG; Vellere I; Piccica M; Bresci S; Maggiore G; Gallo O; Novelli A; Di Muccio T; Gramiccia M; Gradoni L; Gaiera G; Bartoloni A; Zammarchi L
Int J Infect Dis; 2020 Aug; 97():204-207. PubMed ID: 32505874
[TBL] [Abstract][Full Text] [Related]
8. Mucosal leishmaniasis due to Leishmania (Viannia) braziliensis L(V)b in Três Braços, Bahia-Brazil.
Marsden PD
Rev Soc Bras Med Trop; 1994; 27(2):93-101. PubMed ID: 8073158
[TBL] [Abstract][Full Text] [Related]
9. Imported mucosal leishmaniasis in a traveler.
Scope A; Trau H; Bakon M; Yarom N; Nasereddin A; Schwartz E
Clin Infect Dis; 2003 Sep; 37(6):e83-7. PubMed ID: 12955668
[TBL] [Abstract][Full Text] [Related]
10. New World and Old World Leishmania Infections: A Practical Review.
Kevric I; Cappel MA; Keeling JH
Dermatol Clin; 2015 Jul; 33(3):579-93. PubMed ID: 26143433
[TBL] [Abstract][Full Text] [Related]
11. First case of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in Suriname.
Hu RV; Kent AD; Adams ER; van der Veer C; Sabajo LO; Mans DR; de Vries HJ; Schallig HD; Lai A Fat RF
Am J Trop Med Hyg; 2012 May; 86(5):825-7. PubMed ID: 22556081
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Bolivian mucosal leishmaniasis with miltefosine.
Soto J; Toledo J; Valda L; Balderrama M; Rea I; Parra R; Ardiles J; Soto P; Gomez A; Molleda F; Fuentelsaz C; Anders G; Sindermann H; Engel J; Berman J
Clin Infect Dis; 2007 Feb; 44(3):350-6. PubMed ID: 17205440
[TBL] [Abstract][Full Text] [Related]
13. Mucosal leishmaniasis and miltefosine.
Tuon FF; Amato VS
Clin Infect Dis; 2007 Jun; 44(11):1525-6; author reply 1526-7. PubMed ID: 17479959
[No Abstract] [Full Text] [Related]
14. The antifungal compound butenafine eliminates promastigote and amastigote forms of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
Bezerra-Souza A; Yamamoto ES; Laurenti MD; Ribeiro SP; Passero LF
Parasitol Int; 2016 Dec; 65(6 Pt A):702-707. PubMed ID: 27546158
[TBL] [Abstract][Full Text] [Related]
15. Mucocutaneous leishmaniasis: report of a case with massive involvement of nasal, pharyngeal and laryngeal mucosa.
Di Lella F; Vincenti V; Zennaro D; Afeltra A; Baldi A; Giordano D; Pasanisi E; Bacciu A; Bacciu S; Di Lella G
Int J Oral Maxillofac Surg; 2006 Sep; 35(9):870-2. PubMed ID: 16574379
[No Abstract] [Full Text] [Related]
16. Reactivation of mucosal and cutaneous leishmaniasis in a renal transplanted patient.
Tuon FF; Bombonatto GM; Battaglin ER; Sakumoto MH; Amato VS; de Camargo RA; Nicodemo AC
Am J Trop Med Hyg; 2014 Jul; 91(1):81-3. PubMed ID: 24732458
[TBL] [Abstract][Full Text] [Related]
17. Good response to pentamidine isethionate in a case of Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis that was difficult to treat: Case Report.
Ferreira Terceiro BR; Torraca TSS; Braga FPB; Martins ACDC; Brahim LR; Saheki MN; Miranda LFC; Schubach AO; Valete-Rosalino CM
Rev Soc Bras Med Trop; 2019 Jan; 52():e20180236. PubMed ID: 30652793
[TBL] [Abstract][Full Text] [Related]
18. Mucosal leishmaniasis . Current scenario and prospects for treatment.
Amato VS; Tuon FF; Bacha HA; Neto VA; Nicodemo AC
Acta Trop; 2008 Jan; 105(1):1-9. PubMed ID: 17884002
[TBL] [Abstract][Full Text] [Related]
19. Treatment of imported New World cutaneous leishmaniasis in Germany.
Harms G; Scherbaum H; Reiter-Owona I; Stich A; Richter J
Int J Dermatol; 2011 Nov; 50(11):1336-1342. PubMed ID: 22004484
[TBL] [Abstract][Full Text] [Related]
20. [Leishmania braziliensis: report of a pediatric imported case with response to liposomal amphotericin B].
Campos-Muñoz L; Quesada-Cortés A; Martín-Díaz MA; Rubio-Flores C; de Lucas-Laguna R
Actas Dermosifiliogr; 2007; 98(1):42-4. PubMed ID: 17374332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
